General information

Announcements(1)

Program

Sessions

Search presentations

Download PDF for print

Timetable

Mon. Mar 17, 2025

Tue. Mar 18, 2025

Wed. Mar 19, 2025

web_header_en.png

web_icon.png

Profile management

Announcements

Bookmark

Program Type

Login required to view

Password required to view

Presentation Information

Session Details

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

A powerful in vitro system using human iPSC models enables facilitating drug discovery

Co-hosted by: NIKKISO CO., LTD.／FUJIFILM Wako Pure Chemical Corporation

In recent years, the FDA Modernization Act 2.0 has eliminated the  requirement that drugs in development must undergo testing in animals prior to human trials. Therefore, the shift to alternative methods in drug development is steadily progressing, as evidenced by the incorporation of MPS (Microphysiological System) test results into drug application materials. <br>In this seminar, we will introduce human primary cell products and human iPS cell-derived products that are expected to be used as alternatives to animal testing. In the field of human primary cell products, Nikkiso Co., Ltd. has developed the human renal cell spheroid "3D-RPTEC" and will present its efforts for guideline activities and the results of the nephrotoxicity study of puberulic acid. In the field of human iPS cell-derived products, we will introduce the drug discovery research applications of the neural cell product of the "iCell" product line provided by FUJIFILM Cellular Dynamics, as well as the progress of F-hiSIEC, Fujifilm's human iPS cell-derived intestinal epithelial cells.

Introduce Products for Alternatives to Animal Experiments

APPW2025

Presentation Information

[1LS10-02]A powerful in vitro system using human iPSC models enables facilitating drug discovery

Comment